Biotechnology News

September 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Desktop DNA sequencing company GnuBIO moves towards commercialization of the first no prep desktop DNA sequencer. The company is moving to a larger facility in Cambridge, MA - Kendall Square.

September 5, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar to Present a Comparison of Study Start-Up in Emerging Markets with at Outsourcing Clinical Trials New England Conference Followed by a Seminar on Optimizing Time and Money in Clinical Trials

September 5, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that Roche/Genentech’s Perjeta (pertuzumab) which has been available in the U.S. for one...

September 5, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Vanguard announced today that Edward P. Owens, CFA, portfolio manager of Vanguard Health Care Fund, plans to retire on December 31, 2012.

September 5, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) previously announced that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL, from 8:00 a.m. until approximately 3...

September 5, 2012

OKLAHOMA CITY--(BUSINESS WIRE)--The new Magellan(TM) prosthetic leg from Orthocare Innovations brings novel approach by mimicking key features of the human ankle and offers wireless connectivity.

September 5, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X's antibiotic development programs will be featured in a total of 16 posters and presentations at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

September 5, 2012

MANCHESTER, England--(BUSINESS WIRE)--Gentronix Ltd. today announced the company's first contracted screening project in Japan, with a major Japanese pharmaceutical manufacturer, Kowa Company, Ltd.

September 5, 2012

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics, a private company developing inhaled therapeutics with the proven ARCUS(TM) dry powder platform, today announced that Bryan Stuart has been appointed Chief Business Officer.

September 5, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics to host Investor Day 2012 on October 9th. RSVP at www.safeguard.com/InvestorDay2012. Join us to...

September 5, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at three investor conferences in September. The presentations will be webcast live and available for replay from Seattle Genetics’...

September 5, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the Vantera® Clinical Analyzer.

September 5, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter has begun dosing patients with malignant solid tumors in a Phase I clinical trial of a monoclonal antibody.

September 5, 2012

FALMOUTH, Mass.--(BUSINESS WIRE)--Non-Clinical Careers for Physicians is for doctors desiring new challenges.

September 5, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics ™, today announced that it plans to pursue development of TC-5214 as a treatment for overactive...

September 5, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports UK NICE accepts ILUVIEN subgroup data for review - Appraisal Committee meeting rescheduled to October 11, 2012 from September 11, 2012

September 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme announced today that it has initiated a Phase 1 Study of EPZ-5676, a novel small molecule inhibitor of DOT1L, for patients with MLL-r Leukemia, a genetically defined type of acute leukemia.

September 5, 2012

MIDLAND, Mich.--(BUSINESS WIRE)--Following yesterday’s announcement regarding The Dow Chemical Company’s (NYSE:DOW) new business structure, today the Company announced 13 business presidents who have been named to lead Dow’s new Global Businesses...

September 5, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision introduces a new ophthalmic drug delivery system that has demonstrated superior drug retention and tissue penetration for optimized patient care.

September 5, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

September 5, 2012

NEW YORK--(BUSINESS WIRE)--The U.S. Department of Health and Human Services (HHS) and consulting firm Eastern Research Group, Inc. (ERG) have selected the comprehensive trial cost database products from Medidata Solutions.

September 5, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics has appointed Rob Sarisky, Ph.D. as Chief Business Officer to continue FORMA's successful collaboration track record at the forefront of cancer research.

September 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it is seeking nominations for its Science Education Leadership Award program, which honors innovative science teachers in middle and high schools...

September 5, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals to Present New Clinical and Preclinical Research on Its Antibiotic Portfolio at ICAAC

September 5, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--More than half of surveyed pharmaceutical market research teams begin supporting developmental compounds before Phase 3, according to a new study by Cutting Edge Information.

September 5, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals receives Fast Track Designation from the FDA for its lead candidate ALV003.

September 5, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that it expects to submit its Biologic...

September 5, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter of...

September 5, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) today announced that Cornelia Reininger, M.D., Ph.D., has been named Chief Medical Officer of Navidea.

September 5, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--Peter Gabriele will present “Application Challenges in Biomedical Polymer Thermal Processing” at the MedTech Polymers Conference on September 11th at 2:00 p.m. in Chicago, Illinois.

September 5, 2012

TORONTO--(BUSINESS WIRE)--The mature and commoditized United States vascular access device (VAD) market will see slow growth, largely driven by the expansion of the high-utilizing elderly population.

September 5, 2012

BOZEMAN, Mont.--(BUSINESS WIRE)--Today Golden Helix announced the availability of GenomeBrowse, a revolutionary new genomic visualization and annotation platform for DNA and RNA sequence data.

September 5, 2012

SADDLE BROOK, N.J. & AACHEN, Germany--(BUSINESS WIRE)--CircuLite has received CE Marking approval for the SYNERGY Circulatory Support System, a micro-pump designed to halt heart failure progression for those not responding to standard medical...

September 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief...

September 5, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of...

September 5, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration has advised the Company that its New Drug Application (NDA) for crofelemer 125 mg tablets, for the proposed indication...

September 5, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research to Present at Rodman and Renshaw Annual Global Investment Conference

September 5, 2012

--(BUSINESS WIRE)--Biotechnology Industry Organization:   WHAT: The Renewable Fuel Standard sets national goals for production and use of advanced biofuels. Since introduction of the RFS, U.S. companies have worked to rapidly scale up advanced...

September 5, 2012

FREDERICK, Md.--(BUSINESS WIRE)--Reel-to-reel manufacturing on film has significant potential to substantially reduce cost of producing mid-multiplexed molecular tests for global health settings

September 5, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Opens Up Deal Pipeline

September 5, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals and Allos Therapeutics announce expiration of offering period and final completion of tender offer for shares of Allos Therapeutics.

September 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Rodman & Renshaw Annual Global Investment Conference...

September 4, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Morgan Stanley Global Healthcare...

September 4, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (NASDAQ: AFFY) today announced the company's participation in the following investor conferences next week. Rodman & Renshaw Annual Global Investment ConferenceTuesday, September 11, 20121:35...

September 4, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec at Morgan Stanley Healthcare Conference

September 4, 2012

--(BUSINESS WIRE)--Biotechnology Industry Organization:   WHAT: The Renewable Fuel Standard sets national goals for production and use of advanced biofuels. Since introduction of the RFS, U.S. companies have worked to rapidly scale up advanced...

September 4, 2012

SAN ANTONIO--(BUSINESS WIRE)--Larry Miller, MD to receive prestigious BioMed SA 2012 Julio Palmaz Award

September 4, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced that the U.S. Court of Appeals for the Federal Circuit reversed in part a lower court decision of invalidity involving certain asserted patent claims covering ZEGERID®...